Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Poulter

Showing results (21-30 of 179) with videos related to

Pageof 18
Sort By:
Cardiovascular Diabetology|January 5, 2021
History of lower-limb complications and risk of cancer death in people with type 2 diabetesKamel Mohammedi, Stephen Harrap, Giuseppe Mancia, et al.
Hypertension (Dallas, Tex. : 1979)|December 5, 2022
Clinical Utility of Short-Term Blood Pressure Measures to Inform Long-Term Blood Pressure ManagementNelson Wang, Katie Harris, Mark Woodward, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|August 21, 2016
True Resistant Hypertension Following Observed Drug Ingestion: A Systematic EvaluationJill Bunker, Choon-Lan Chang, Neil Chapman, et al.
Lancet (London, England)|August 31, 2018
Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy study: 16-year follow-up results of a randomised factorial trialAjay Gupta, Judith Mackay, Andrew Whitehouse, et al.
Lancet (London, England)|May 7, 2017
Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phaseAjay Gupta, David Thompson, Andrew Whitehouse, et al.
Global Heart|July 28, 2015
Reducing Premature Cardiovascular Mortality By 2025: The World Heart Federation RoadmapPablo Perel, Eduardo Bianco, Neil Poulter, et al.
Diabetes, Obesity & Metabolism|April 1, 2018
Use of the waist-to-height ratio to predict cardiovascular risk in patients with diabetes: Results from the ADVANCE-ON studyKarin Rådholm, John Chalmers, Toshiaki Ohkuma, et al.
Global Heart|July 28, 2015
Adapting the World Heart Federation Roadmaps at the National Level: Next Steps and ConclusionsPablo Perel, Eduardo Bianco, Neil Poulter, et al.
BMJ Open|March 16, 2018
A protocol for an economic evaluation of a polypill in patients with established or at high risk of cardiovascular disease in a UK NHS setting: RUPEE (NHS) studyCatriona Crossan, Hakim-Moulay Dehbi, Hilarie Williams, et al.
Global Heart|July 28, 2015
Reducing Cardiovascular Mortality Through Prevention and Management of Raised Blood Pressure: A World Heart Federation RoadmapAlma J Adler, Dorairaj Prabhakaran, Pascal Bovet, et al.
Pageof 18

Showing results (21-30 of 179) with videos related to

Sort By:
Pageof 18
Cardiovascular Diabetology|January 5, 2021
History of lower-limb complications and risk of cancer death in people with type 2 diabetesKamel Mohammedi, Stephen Harrap, Giuseppe Mancia, et al.
Hypertension (Dallas, Tex. : 1979)|December 5, 2022
Clinical Utility of Short-Term Blood Pressure Measures to Inform Long-Term Blood Pressure ManagementNelson Wang, Katie Harris, Mark Woodward, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|August 21, 2016
True Resistant Hypertension Following Observed Drug Ingestion: A Systematic EvaluationJill Bunker, Choon-Lan Chang, Neil Chapman, et al.
Lancet (London, England)|August 31, 2018
Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy study: 16-year follow-up results of a randomised factorial trialAjay Gupta, Judith Mackay, Andrew Whitehouse, et al.
Lancet (London, England)|May 7, 2017
Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phaseAjay Gupta, David Thompson, Andrew Whitehouse, et al.
Global Heart|July 28, 2015
Reducing Premature Cardiovascular Mortality By 2025: The World Heart Federation RoadmapPablo Perel, Eduardo Bianco, Neil Poulter, et al.
Diabetes, Obesity & Metabolism|April 1, 2018
Use of the waist-to-height ratio to predict cardiovascular risk in patients with diabetes: Results from the ADVANCE-ON studyKarin Rådholm, John Chalmers, Toshiaki Ohkuma, et al.
Global Heart|July 28, 2015
Adapting the World Heart Federation Roadmaps at the National Level: Next Steps and ConclusionsPablo Perel, Eduardo Bianco, Neil Poulter, et al.
BMJ Open|March 16, 2018
A protocol for an economic evaluation of a polypill in patients with established or at high risk of cardiovascular disease in a UK NHS setting: RUPEE (NHS) studyCatriona Crossan, Hakim-Moulay Dehbi, Hilarie Williams, et al.
Global Heart|July 28, 2015
Reducing Cardiovascular Mortality Through Prevention and Management of Raised Blood Pressure: A World Heart Federation RoadmapAlma J Adler, Dorairaj Prabhakaran, Pascal Bovet, et al.
Pageof 18